MH
Mark Hillman
Hillman Capital Management13F filer
Intrinsic-value driven value — as the firm describes itselfPortfolio as of Jun 30, 2026Filed Aug 14, 2026
Quarter ended Jun 30, 2026, from the 13F filed Aug 14, 2026Changes are against the quarter ended Mar 31, 2026U.S.-listed shares only — no bonds, cash, shorts or foreign listings
Portfolio value
$138.15M
As reported, at quarter-end prices
Positions
54
U.S.-listed companies held
3 new · 5 exited this quarter
Concentration
36%in the top 10
Weight held in the ten largest positions
This quarter
14added · 35trimmed
Positions resized since the prior quarter
What changed this quarter
See which positions were opened, increased, reduced or closed—and how large those positions are now.
24 of 57 reported changes are available in this view.
| Company | Reported move | Change in shares | Portfolio weight now |
|---|---|---|---|
| New position | Not held in prior quarter | 3.71% | |
VEEVA SYS INCVEEV | New position | Not held in prior quarter | 1.80% |
| New position | Not held in prior quarter | 0.28% | |
DUPONT DE NEMOURS INC | Sold out | Position closed | No longer held |
GE AEROSPACEGE | Sold out | Position closed | No longer held |
SPDR SERIES TRUST | Sold out | Position closed | No longer held |
ISHARES TR | Sold out | Position closed | No longer held |
SPDR SER TR | Sold out | Position closed | No longer held |
| Added to | +22.4% | 1.76% | |
| Added to | +24.7% | 1.55% |
Showing 1–10 of 57 changes · Share classes count separatelyBars: square-root scale · Percentages shown · — unavailable
Changes compare reported share counts at quarter-end. The filing does not tell us when trades happened or why the investor made them.
Portfolio
| Ticker | Issuer | % of portfolio | Reported price | Value | Shares |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORPDECREASED -17.8% | 4.15% | $103.45 | $5.74M | 55.5K |
| BIIB | BIOGEN INCDECREASED -18.8% | 3.75% | $216.06 | $5.18M | 24.0K |
| DD | DUPONT DE NEMOURS INCNEW | 3.71% | $135.64 | $5.12M | 37.7K |
| WBD | WARNER BROS DISCOVERY INC· COM SER ADECREASED -3.2% | 3.67% | $26.66 | $5.07M | 190.0K |
| BAX | BAXTER INTL INCDECREASED -4.6% | 3.64% | $21.32 | $5.03M | 236.0K |
| IFF | INTERNATIONAL FLAVORS&FRAGRADECREASED -13.6% | 3.61% | $79.22 | $4.98M | 62.9K |
| GSK | GSK PLC· SPONSORED ADRDECREASED -5.2% | 3.51% | $52.42 | $4.84M | 92.4K |
| KMX | CARMAX INCDECREASED -16.3% | 3.50% | $52.89 | $4.83M | 91.4K |
| BA | BOEING CODECREASED -3.4% | 3.38% | $216.47 | $4.67M | 21.6K |
| ZBH | ZIMMER BIOMET HOLDINGS INCDECREASED -3.2% | 3.36% | $86.09 | $4.64M | 53.9K |
Showing 1–10 of 54 · the top 10 are 36.3% of the reported portfolioEach row opens the company · how we read 13F filings
Reported price is this manager's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what they paid. 13F reports no cost basis.
All 54 positions, with reported prices and share counts, open with a free account.
Connected research
Follow this portfolio through time.
Compare reported holdings across quarters and explore the businesses behind them with your connected AI:
- “What has Mark Hillman been buying over the last year, quarter by quarter?”
- “Which of my funds already hold what Hillman Capital Management holds — and how much overlap is that?”
- “Which other superinvestors moved the same way this quarter?”
See how it works →All research tools with a subscription. Use your own AI account.